NDC11 67226205003
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 67226-2050-03 | 67226-2050 |
| 67226-2050-3 | 67226-2050 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acne Treatment | BENZOYL PEROXIDE | Vivier Pharma, Inc. | b4844539-bdd2-42a6-b946-6028de4f3cf1 | 2023-10-27 | Warnings | 67226-2050-3 67226-2050 67226205003 |
| Acne Treatment System | BENZOYL PEROXIDE, SALICYLIC ACID | Vivier Pharma, Inc. | d39ee6a2-5d65-4198-82d9-deb83471f312 | 2023-10-27 | Warnings | 67226-2050-3 67226205003 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.